Allely M C, Alps B J
Syntex Research Centre, Riccarton, Edinburgh, Scotland.
Arch Int Pharmacodyn Ther. 1988 Sep-Oct;295:138-46.
The effects of the novel Class Ia/III antiarrhythmic compound RS-87337 on canine myocardial conduction were compared with those of the Class I antiarrhythmic disopyramide. RS-87337 had no effects on intra-atrial (I-A) or intra-ventricular (I-V) conduction parameters up to 10 mg.kg-1 i.v. (n = 6). Only one incidence of atrioventricular (A-V) block occurred at 10 mg.kg-1 at a pacing frequency of 261 beat.min-1. Disopyramide (5-10 mg.kg-1 i.v., n = 6) produced a frequency-dependent I-A conduction block and also significantly increased resting and paced A-V conduction times. Overall, disopyramide exhibited atrioselectivity while RS-87337 appeared more selective for ventricular conduction, possibly produced by a balance of its mixed Class Ia/III properties. RS-87337 was not cardiodepressant in the normal canine myocardium and produced no adverse effects on conduction parameters at doses up to 10 mg.kg-1 i.v.
将新型Ia/III类抗心律失常化合物RS-87337对犬心肌传导的影响与I类抗心律失常药物丙吡胺的影响进行了比较。静脉注射RS-87337达10mg.kg-1时(n = 6),对心房内(I-A)或心室内(I-V)传导参数无影响。仅在10mg.kg-1、起搏频率为261次/分钟时出现1例房室(A-V)阻滞。丙吡胺(静脉注射5-10mg.kg-1,n = 6)产生频率依赖性I-A传导阻滞,并且还显著增加静息和起搏时的A-V传导时间。总体而言,丙吡胺表现出心房选择性,而RS-87337似乎对心室传导更具选择性,这可能是由其Ia/III类混合特性的平衡所致。RS-87337对正常犬心肌无心脏抑制作用,静脉注射剂量达10mg.kg-1时对传导参数无不良影响。